MAIA Biotechnology Announces $2.44 Million Private Placement
October 28, 2024 07:00 PM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive agreements…